Evidence map›Paper›PMID 30991216›Full record

ArticleBiomaterials2019

Injectable osteogenic microtissues containing mesenchymal stromal cells conformally fill and repair critical-size defects.

Ramkumar T Annamalai, Xiaowei Hong, Nicholas G Schott, Gopinath Tiruchinapally, Benjamin Levi, Jan P Stegemann

Abstract read
In one paragraph

Article in Biomaterials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ramkumar T AnnamalaiDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, United States.
Xiaowei HongDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, United States.
Nicholas G SchottDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, United States.
Gopinath TiruchinapallyDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, United States.
Benjamin LeviDepartment of Surgery, University of Michigan, Ann Arbor, United States.
Jan P StegemannDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, United States. Electronic address: jpsteg@umich.edu.

Funding

University of Michigan Postbaccalaureate Research Education Program (UM PREP)R25GM086262 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALLEN, BENJAMIN · 2009 to 2024
$6.1M
Cellular Biotechnology Training Program (CBTP) - Years 31-35T32GM145304 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Guizhi Zhu · 2022 to 2026
$2.6M
Microscale Mechanobiology for Musculoskeletal Tissue Engineering using Advanced Ultrasound TechniquesR01DE026630 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DENG, CHERI X, STEGEMANN, JAN P. · 2017 to 2021
$1.8M
Bone Regeneration Using Osteogenic and Vasculogenic Tissue ModulesR01AR062636 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI STEGEMANN, JAN P. · 2014 to 2018
$1.7M
Targeting Molecular and Cellular Mediators of Inflammation to Prevent Pathologic Cell Differentiation and Heterotopic OssificationR01AR071379 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI LEVI, BENJAMIN · 2017 to 2021
$1.5M
Developing New Diagnostic and Timed, TAK1 Specific Treatment Strategies for Trauma Induced Heterotopic OssificationR01GM123069 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI LEVI, BENJAMIN · 2017 to 2020
$1.2M
Novel Pathway and Prevention Strategy for Heterotopic OssificationK08GM109105 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LEVI, BENJAMIN · 2014 to 2017
$785k
NIAMS NIH HHS R01 AR062636NIAMS NIH HHS R01 AR071379NIDCR NIH HHS R01 DE026630NIGMS NIH HHS K08 GM109105NIGMS NIH HHS R01 GM123069NIGMS NIH HHS R25 GM086262NIGMS NIH HHS T32 GM145304
6 · The paper itself

Abstract

Repair of complex fractures with bone loss requires a potent, space-filling intervention to promote regeneration of bone. We present a biomaterials-based strategy combining mesenchymal stromal cells (MSC) with a chitosan-collagen matrix to form modular microtissues designed for delivery through a needle to conformally fill cavital defects. Implantation of microtissues into a calvarial defect in the mouse showed that osteogenically pre-differentiated MSC resulted in complete bridging of the cavity, while undifferentiated MSC produced mineralized tissue only in apposition to native bone. Decreasing the implant volume reduced bone regeneration, while increasing the MSC concentration also attenuated bone formation, suggesting that the cell-matrix ratio is important in achieving a robust response. Conformal filling of the defect with microtissues in a carrier gel resulted in complete healing. Taken together, these results show that modular microtissues can be used to augment the differentiated function of MSC and provide an extracellular environment that potentiates bone repair.

Indexed as

AnimalsBone RegenerationCell DifferentiationCells, CulturedChitosanCollagenMagnetic Resonance SpectroscopyMesenchymal Stem CellsMice, Inbred C57BLMice, TransgenicOsteogenesisChitosanCollagenBone regenerationChitosan and collagenCritical size defectMesenchymal stromal cellsMicrotissuesNon-invasive delivery

Identifiers

PMID30991216
PMCPMC6500486

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.